證券時報e公(gong)(gong)(gong)司訊，魚躍(yue)醫療(002223)10月21日晚(wan)披露(lu)三(san)季報，公(gong)(gong)(gong)司前三(san)季度(du)(du)(du)營收(shou)48.48億(yi)元(yuan)(yuan)，同(tong)比(bi)增(zeng)長36.33%；凈(jing)利(li)(li)潤15.1億(yi)元(yuan)(yuan)，同(tong)比(bi)增(zeng)長111.84%。公(gong)(gong)(gong)司預計2020年度(du)(du)(du)凈(jing)利(li)(li)潤16.56億(yi)元(yuan)(yuan)至(zhi)17.31億(yi)元(yuan)(yuan)，同(tong)比(bi)增(zeng)長120%至(zhi)130%；公(gong)(gong)(gong)司各板塊常規業務開展(zhan)順利(li)(li)，主要產品(pin)銷量穩(wen)步增(zeng)長。股東(dong)名單方面(mian)，北向資金持股比(bi)例由(you)二季度(du)(du)(du)末的3.22%升至(zhi)5.36%。